设为首页 加入收藏

TOP

REVLIMID [lenalidomide] capsules(十四)
2017-08-29 10:14:36 来源: 作者: 【 】 浏览:20179次 评论:0
.8) 14 (2.6)
Pain in extremity f 79 (14.8) 66 (12.2) 61 (11.3) 8 (1.5) 8 (1.5) 7 (1.3)
Musculoskeletal pain f 67 (12.6) 59 (10.9) 36 (6.7) <1% <1% <1%
Musculoskeletal chest pain f 60 (11.3) 51 (9.4) 39 (7.2) 6 (1.1) <1% <1%
Muscular weakness f 43 (8.1) 35 (6.5) 29 (5.4) <1% 8 (1.5) <1%
Neck pain f 40 (7.5) 19 (3.5) 10 (1.8) <1% <1% <1%
Infections and infestations    
Bronchitis c 90 (16.9) 59 (10.9) 43 (7.9) 9 (1.7) 6 (1.1) 3 (0.6)
Nasopharyngitis f 80 (15.0) 54 (10.0) 33 (6.1) 0 (0.0) 0 (0.0) 0 (0.0)
Urinary tract infection f 76 (14.3) 63 (11.7) 41 (7.6) 8 (1.5) 8 (1.5) <1%
Upper respiratory tract infection c % f 69 (13.0) 53 (9.8) 31 (5.7) <1% 8 (1.5) <1%
Pneumonia c @ 93 (17.5) 87 (16.1) 56 (10.4) 60 (11.3) 57 (10.5) 41 (7.6)
Respiratory tract infection % 35 (6.6) 25 (4.6) 21 (3.9) 7 (1.3) 4 (0.7) 1 (0.2)
Influenza f 33 (6.2) 23 (4.3) 15 (2.8) <1% <1% 0 (0.0)
Gastroenteritis f 32 (6.0) 17 (3.1) 13 (2.4) 0 (0.0) <1% <1%
Lower respiratory tract infection 29 (5.5) 14 (2.6) 16 (3.0) 10 (1.9) 3 (0.6) 3 (0.6)
Rhinitis f 29 (5.5) 24 (4.4) 14 (2.6) 0 (0.0) 0 (0.0) 0 (0.0)
Cellulitisc <5% <5% <5% 8 (1.5) 3 (0.6) 2 (0.4)
Sepsis c @ 33 (6.2) 26 (4.8) 18 (3.3) 26 (4.9) 20 (3.7) 13 (2.4)
Nervous system disorders     
Headache f 75 (14.1) 52 (9.6) 56 (10.4) <1% <1% <1%
Dysgeusia f 39 (7.3) 45 (8.3) 22 (4.1) <1% 0 (0.0) <1%
Blood and lymphatic system disordersd    
Anemia 233 (43.8) 193 (35.7) 229 (42.3) 97 (18.2) 85 (15.7) 102 (18.9)
Neutropenia 186 (35.0) 178 (33.0) 328 (60.6) 148 (27.8) 143 (26.5) 243 (44.9)
Thrombocytopenia 104 (19.5) 100 (18.5) 135 (25.0) 44 (8.3) 43 (8.0) 60 (11.1)
Febrile neutropenia 7 (1.3) 17 (3.1) 15 (2.8) 6 (1.1) 16 (3.0) 14 (2.6)
Pancytopenia 5 (0.9) 6 (1.1) 7 (1.3) 1 (0.2) 3 (0.6) 5 (0.9)
Respiratory, thoracic and mediastinal disorders    
Cough f 121 (22.7) 94 (17.4) 68 (12.6) <1% <1% <1%
Dyspneac,e 117 (22.0) 89 (16.5) 113 (20.9) 30 (5.6) 22 (4.1) 18 (3.3)
Epistaxis f 32 (6.0) 31 (5.7) 17 (3.1) <1% <1% 0 (0.0)
Oropharyngeal pain f 30 (5.6) 22 (4.1) 14 (2.6) 0 (0.0) 0 (0.0) 0 (0.0)
Dyspnea exertional e 27 (5.1) 29 (5.4) <5% 6 (1.1) 2 (0.4) 0 (0.0)
Metabolism and nutrition disorders    
Decreased appetite 123 (23.1) 115 (21.3) 72 (13.3) 14 (2.6) 7 (1.3) 5 (0.9)
Hypokalemia % 91 (17.1) 62 (11.5) 38 (7.0) 35 (6.6) 20 (3.7) 11 (2.0)
Hyperglycemia 62 (11.7) 52 (9.6) 19 (3.5) 28 (5.3) 23 (4.3) 9 (1.7)
Hypocalcemia 57 (10.7) 56 (10.4) 31 (5.7) 23 (4.3) 19 (3.5) 8 (1.5)
Dehydration % 25 (4.7) 29 (5.4) 17 (3.1) 8 (1.5) 13 (2.4) 9 (1.7)
Gout e <5% <5% <5% 8 (1.5) 0 (0.0) 0 (0.0)
Diabetes mellitus % e <5% <5% <5% 8 (1.5) 4 (0.7) 2 (0.4)
Hypophosphatemia e <5% <5% <5% 7 (1.3) 3 (0.6) 1 (0.2)
Hyponatremia % e <5% <5% <5% 7 (1.3) 13 (2.4) 6 (1.1)
Skin and subcutaneous tissue disorders    
Rash 139 (26.1) 151 (28.0) 105 (19.4) 39 (7.3) 38 (7.0) 33 (6.1)
Pruritus f 47 (8.8) 49 (9.1) 24 (4.4) <1% <1% <1%
Psychiatric disorders    
Insomnia 147 (27.6) 127 (23.5) 53 (9.8) 4 (0.8) 6 (1.1) 0 (0.0)
Depression 58 (10.9) 46 (8.5) 30 (5.5) 10 (1.9) 4 (0.7) 1 (0.2)
Vascular disorders    
Deep vein thrombosisc% 55 (10.3) 39 (7.2) 22 (4.1) 30 (5.6) 20 (3.7) 15 (2.8)
Hypotensionc% 51 (9.6) 35 (6.5) 36 (6
以下是“全球医药”详细资料
Tags: 责任编辑:admin
首页 上一页 11 12 13 14 15 16 17 下一页 尾页 14/50/50
】【打印繁体】【投稿】【收藏】 【推荐】【举报】【评论】 【关闭】 【返回顶部
分享到QQ空间
分享到: 
上一篇ACZONE(dapsone) Gel, 7.5%, for .. 下一篇KISQALI FEMARA CO-PACK (ribocic..

相关栏目

最新文章

图片主题

热门文章

推荐文章

相关文章

广告位